Max Healthcare Institute disclosed that its wholly-owned subsidiary Alps Hospital Limited received a show cause cum demand notice from the Directorate General of Goods & Services Tax Intelligence (DGGI). The notice was issued under section 74(1) and 74(A)(1) of the Central Goods and Services Tax Act, 2017.

The regulatory action stems from allegations of non-payment of GST on variable management fees by Alps Hospital. The company received the notice on August 25, 2026, at 5:12 pm.

Financial Implications

The show cause notice outlines significant financial demands including principal tax, interest, and penalties. The total alleged liability is detailed below.

The DGGI Mumbai Zonal Unit has also claimed applicable interest on the principal demand. The company has stated that management is in the process of filing submissions against the demand.

What the Numbers Show

The structure of the demand indicates a severe regulatory stance. The two penalty components are each equal to the full principal GST demand of ₹55.23 crore. This results in a total potential liability of approximately ₹165.70 crore if the allegations are upheld without mitigation, representing a three-fold multiple of the original tax dispute.

Max Healthcare Institute Ltd reported 16% year-on-year revenue growth to ₹2,835 crore for Q1FY27. The company’s management provided detailed updates on capacity expansion, strategic acquisitions, and a new venture into medical education during its earnings conference call held on August 14, 2026.

The healthcare provider disclosed these results alongside an announcement that it will participate in the Motilal Oswal 22nd Annual Global Investor Conference on August 18, 2026.

Financial Performance

Max Healthcare’s operating EBITDA increased 15% to ₹704 crore, maintaining an operating EBITDA margin of 24.8%. Profit after tax stood at ₹357 crore, up from ₹345 crore in Q1FY26. The company generated free cash flows of ₹397 crore during the quarter.

Operational Highlights

Average Revenue Per Occupied Bed (ARPOB) stood at ₹81,900, up 5% year-on-year. Occupied Bed Days increased by 10% year-on-year and 5% quarter-on-quarter. Average Length of Stay reduced by 4% over the trailing quarter.

International patient revenue reached ₹247 crore, registering 18% year-on-year growth and accounting for 9% of hospital revenues. Digital revenue from online marketing and web-based appointments totaled ₹941 crore, representing approximately 32% of overall revenue. Website traffic crossed 97 lakh sessions during the quarter, growing by 41% year-on-year.

Expansion and Acquisitions

The company continues to expand through organic growth and acquisitions. At Max Smart, 50% of the 400-bed brownfield tower is operationalized, with the remaining beds expected in the current quarter. Nanavati Max will operationalize its remaining 50 beds this quarter, while Phase 2 expansion work has commenced.

The recently acquired Kalinga Hospital Ltd in Bhubaneswar contributed ₹19 crore in revenue and ₹2 crore in EBITDA in the post-acquisition period. The hospital recorded an occupancy of 50% and ARPOB of ₹35,000. Management indicated significant headroom for growth, targeting a 50% to 80% enhancement in both metrics over the next 12 months through integration and infrastructure upgrades.

The board approved a capital expenditure of ₹425 crore for a new brownfield tower at Max Vaishali, adding 202 beds to the existing 387-bed facility. Construction has commenced, with commissioning expected before FY30. Additionally, the company acquired the SPV for the Pune greenfield project.

Medical Education Initiative

Max Healthcare announced plans to enter the medical education business following in-principle board approval. This move leverages recent changes in National Medical Commission guidelines allowing for-profit entities to open medical colleges. Management estimates a capital requirement of ₹300 crore for a 150-seat medical college, projecting Return on Capital Employed (ROCE) of more than 25%. The company intends to fund this entirely through internal accruals and start commercial operations over the next few years.

Cash Flow and Balance Sheet

Net debt stood at ₹2,384 crore as on June 30, 2026, compared to ₹1,908 crore at the end of March 2026. The increase includes ₹153 crore towards the Kalinga acquisition and put option liability for the Pune project. The net debt-to-EBITDA ratio remains below 1. Management noted that Days Sales Outstanding (DSO) rose from 87 days to 95 days due to lumpiness in CGHS and PSU collections, impacting free cash flow conversion.

What the Numbers Show

The divergence between the 15% growth in operating EBITDA and the 3% growth in profit after tax highlights the impact of capital expenditure on near-term profitability. With depreciation and amortization rising to ₹150 crore from ₹117 crore in the previous year, the company is actively deploying capital into brownfield expansions. Furthermore, the rise in DSO from 87 to 95 days indicates working capital pressure from institutional payers, which absorbed a portion of the operating cash flow despite strong top-line growth.

Investor Conference Details

In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Max Healthcare announced its participation in the Motilal Oswal 22nd Annual Global Investor Conference. Representatives will hold physical meetings at the Grand Hyatt in Mumbai on August 18, 2026. Dhiraj Aroraa, EVP - Company Secretary and Compliance Officer, signed the disclosure dated August 12, 2026.